Stage III Childhood Lymphoblastic Lymphoma Active Not Recruiting Phase 3 Trials for Bortezomib (DB00188)

IndicationStatusPhase
DBCOND0030479 (Stage III Childhood Lymphoblastic Lymphoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs